Deep Track Capital, LP Spring Works Therapeutics, Inc. Transaction History
Deep Track Capital, LP
- $2.71 Billion
- Q3 2024
A detailed history of Deep Track Capital, LP transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 3,843,900 shares of SWTX stock, worth $161 Million. This represents 4.54% of its overall portfolio holdings.
Number of Shares
3,843,900
Previous 3,700,000
3.89%
Holding current value
$161 Million
Previous $139 Million
11.64%
% of portfolio
4.54%
Previous 4.57%
Shares
8 transactions
Others Institutions Holding SWTX
# of Institutions
238Shares Held
69.8MCall Options Held
144KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA6.71MShares$281 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$235 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$147 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$143 Million5.82% of portfolio
-
State Street Corp Boston, MA3.09MShares$129 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.61B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...